Logo image of BYL-DB.CA

BAYLIN TECHNOLOGIES INC (BYL-DB.CA) Stock Fundamental Analysis

TSX:BYL-DB - Toronto Stock Exchange - CA072819AB17 - Currency: CAD

86  -2 (-2.27%)

Fundamental Rating

1

BYL-DB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 15 industry peers in the Electronic Equipment, Instruments & Components industry. BYL-DB may be in some trouble as it scores bad on both profitability and health. BYL-DB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BYL-DB had negative earnings in the past year.
BYL-DB had a negative operating cash flow in the past year.
BYL-DB had negative earnings in each of the past 5 years.
BYL-DB had negative operating cash flow in 4 of the past 5 years.
BYL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFBYL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

BYL-DB has a Return On Assets of -35.02%. This is in the lower half of the industry: BYL-DB underperforms 73.33% of its industry peers.
Industry RankSector Rank
ROA -35.02%
ROE N/A
ROIC N/A
ROA(3y)-39.45%
ROA(5y)-28.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYL-DB.CA Yearly ROA, ROE, ROICBYL-DB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10K 20K 30K

1.3 Margins

Looking at the Gross Margin, with a value of 40.42%, BYL-DB is doing worse than 66.67% of the companies in the same industry.
BYL-DB's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BYL-DB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.55%
GM growth 5Y0.83%
BYL-DB.CA Yearly Profit, Operating, Gross MarginsBYL-DB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

2

2. Health

2.1 Basic Checks

BYL-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
BYL-DB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BYL-DB has more shares outstanding
The debt/assets ratio for BYL-DB has been reduced compared to a year ago.
BYL-DB.CA Yearly Shares OutstandingBYL-DB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
BYL-DB.CA Yearly Total Debt VS Total AssetsBYL-DB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 118.99 indicates that BYL-DB is not in any danger for bankruptcy at the moment.
BYL-DB has a better Altman-Z score (118.99) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 118.99
ROIC/WACCN/A
WACC7.8%
BYL-DB.CA Yearly LT Debt VS Equity VS FCFBYL-DB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

BYL-DB has a Current Ratio of 0.86. This is a bad value and indicates that BYL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BYL-DB (0.86) is worse than 80.00% of its industry peers.
BYL-DB has a Quick Ratio of 0.86. This is a bad value and indicates that BYL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.55, BYL-DB is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.55
BYL-DB.CA Yearly Current Assets VS Current LiabilitesBYL-DB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

3

3. Growth

3.1 Past

BYL-DB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
Looking at the last year, BYL-DB shows a very strong growth in Revenue. The Revenue has grown by 30.98%.
The Revenue for BYL-DB have been decreasing by -11.72% on average. This is quite bad
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)30.98%
Revenue growth 3Y-15.18%
Revenue growth 5Y-11.72%
Sales Q2Q%-11.97%

3.2 Future

The Earnings Per Share is expected to grow by 37.54% on average over the next years. This is a very strong growth
BYL-DB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.34% yearly.
EPS Next Y71.14%
EPS Next 2Y37.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.23%
Revenue Next 2Y-4.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BYL-DB.CA Yearly Revenue VS EstimatesBYL-DB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BYL-DB.CA Yearly EPS VS EstimatesBYL-DB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BYL-DB. In the last year negative earnings were reported.
Also next year BYL-DB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYL-DB.CA Price Earnings VS Forward Price EarningsBYL-DB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -1K -2K -3K -4K -5K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYL-DB.CA Per share dataBYL-DB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as BYL-DB's earnings are expected to grow with 37.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BYL-DB!.
Industry RankSector Rank
Dividend Yield N/A

BAYLIN TECHNOLOGIES INC

TSX:BYL-DB (2/10/2025, 7:00:00 PM)

86

-2 (-2.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-06 2025-03-06
Inst Owners0.61%
Inst Owner ChangeN/A
Ins Owners1.87%
Ins Owner ChangeN/A
Market Cap13.02B
Analysts47.5
Price Target59.71 (-30.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.51%
Min EPS beat(2)-98.02%
Max EPS beat(2)67%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.72%
Min Revenue beat(2)-4.19%
Max Revenue beat(2)9.63%
Revenue beat(4)2
Avg Revenue beat(4)39.02%
Min Revenue beat(4)-26.46%
Max Revenue beat(4)177.08%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-150%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)17.75%
Revenue NQ rev (3m)-29.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 95.87
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.9
BVpS-0.04
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.42%
FCFM N/A
ROA(3y)-39.45%
ROA(5y)-28.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.55%
GM growth 5Y0.83%
F-Score4
Asset Turnover2.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.14%
Cap/Sales 0.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.55
Altman-Z 118.99
F-Score4
WACC7.8%
ROIC/WACCN/A
Cap/Depr(3y)13.85%
Cap/Depr(5y)37.3%
Cap/Sales(3y)1.29%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y71.14%
EPS Next 2Y37.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.98%
Revenue growth 3Y-15.18%
Revenue growth 5Y-11.72%
Sales Q2Q%-11.97%
Revenue Next Year-13.23%
Revenue Next 2Y-4.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.19%
OCF growth 3YN/A
OCF growth 5YN/A